Flow Cytometry Market by Products (Instrument, Kit & Reagent, Software & Services, and Others), End-users (Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Others), Technologies (Cell-based Flow Cytometry and Bead-based Flow Cytometry), Applications (Hematology, Drug Discovery, Stem Cell Therapy, Oncology, Organ Transplantation, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global flow cytometry market size was valued at nearly USD 4.7 Billion in 2022 and is anticipated to reach USD 9.47 Billion by 2031, expanding at a CAGR of 8.1% during the forecast period, 2023 – 2031. The growth of the market is attributed to increasing use of AI platforms in flow cytometry workflows, as well as developments in flow cytometry software and growing public-private collaborations in immunology and immuno-oncology research.
Flow cytometry has evolved as a critical technique for drug discovery and development safety and exploratory objectives. This technology is utilized throughout the research process, from pre-clinical trials to target selection and screening. Flow cytometry assess a huge number of particles in a short amount of time and offer statistically reliable information on cell populations. These capabilities, together with its multi-parametric approach, make flow cytometry more suitable for use in drug research and development procedures in the pharmaceutical and biopharmaceutical sectors.
Flow cytometry is a versatile instrument that may be utilized for a wide range of cell study applications, from phenotyping to cell health and viability. Flow cytometry's two most significant benefits are its capacity to measure a large number of parameters two to 30 or more on the same sample and its ability to gather data from millions of cells in a couple of seconds.
A flow cytometer has three primary components: fluidics, optics, and electronics, which work together to offer a full cell analysis system. The rising incidence of chronic medical conditions like as HIV/AIDS and cancer necessitates toxicity testing as well as an accurate, speedy, and sensitive prognostic approach, which is generating a positive perspective for market growth.
In 2012, prochymal, a stem-cell therapy, was provisionally licensed in Canada for the treatment of acute graft-vs-host disease in children who were refractory to steroids. Cell and gene therapy firms performed better, according to ARM, which computed stock performance that outperformed the larger NBI index in its study. Corona virus mutation and case of individual affecting with these new variants are creating an opportunity for market growth.
Flow Cytometry Market Trends, Drivers, Restraints, and Opportunities
- Rapid growth of healthcare and medical equipment industries are major factors propelling the market.
- Growing demand for novel drugs discovery is anticipated to drive the market in the coming years.
- Associations and government investments are encouraging the development of gene and cell technologies which is expected to fuel the market.
- Increasing cases of cancer, HIVs, and other chronic diseases is projected to boost the market during the forecast period.
- Rising demands for quick diagnosis is projected to drive the market in coming years.
- High maintenance costs and several other indirect expenses is expected to hinder the market growth.
- Alternative techniques act as key challenges that can restrict the market expansion during the forecast period.
- Boosting research endeavors in major nations, lowering regulatory impediments, and ongoing development of healthcare infrastructures are estimated to create immense opportunities for the market players.
Scope of Flow Cytometry Market Report
The report on the global flow cytometry market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Flow Cytometry Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Products (Instrument, Kit & Reagent, Software & Services, and Others), End Users (Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Others), Technologies (Cell-based Flow Cytometry and Bead-based Flow Cytometry), Applications (Hematology, Drug Discovery, Stem Cell Therapy, Oncology, Organ Transplantation, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
DANAHER corporation (Beckman Coulter, Inc.); Bio-Rad Laboratories Inc.; Luminex Corporation; Sysmex Corporation; Becton; Dickinson and Company |
Flow Cytometry Market Segment Insights
The kit & reagent segment is projected to hold a major market share
Based on products, the flow cytometry market is divided into instrument, kit & reagent, software & services, and others. The kit & reagent segments is expected to represent a key share of the market during the forecast period owing to rising demand for development and commercialization of high-quality application-specific reagents, and assays and continuous requirement of flow cytometry reagents.
The hospitals & clinics segment is expected to grow at a rapid pace
On the basis of end users, the flow cytometry market is segmented into academia & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The hospitals & clinics segment is expected to account for a key share of the market in the coming years due to increasing demand for diagnosis instruments.
The cell-based flow cytometry segment is anticipated to expand at rapid CAGR
In terms of technologies, the flow cytometry market is bifurcated into cell-based flow cytometry and bead-based flow cytometry. The cell-based flow cytometry segment is expected to constitute a key share of the market during the forecast period due to wide applications in clinical researches such as cell function assays, and apoptosis.
The stem cell therapy segment is expected grow at a rapid pace
On the basis of applications, the flow cytometry market is segmented into hematology, drug discovery, stem cell therapy, oncology, organ transplantation, and others. The stem cell therapy segment is expected to grow at a rapid pace during the forecast period due to increasing number of researches in stem cell technologies also growing adoption of recombinant DNA technology for antibody production.
Regional Analysis
On the basis of regions, the flow cytometry market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at a high CAGR during the forecast period. The regional market growth is attributed to R&D spending and federal support in the region is increasing.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Flow Cytometry Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Flow Cytometry Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Flow Cytometry Market - Supply Chain
4.5. Global Flow Cytometry Market Forecast
4.5.1. Flow Cytometry Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Flow Cytometry Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Flow Cytometry Market Absolute $ Opportunity
5. Global Flow Cytometry Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Flow Cytometry Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Flow Cytometry Demand Share Forecast, 2019-2026
6. North America Flow Cytometry Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Flow Cytometry Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Flow Cytometry Demand Share Forecast, 2019-2026
7. Latin America Flow Cytometry Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Flow Cytometry Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Flow Cytometry Demand Share Forecast, 2019-2026
8. Europe Flow Cytometry Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Flow Cytometry Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Flow Cytometry Demand Share Forecast, 2019-2026
9. Asia Pacific Flow Cytometry Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Flow Cytometry Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Flow Cytometry Demand Share Forecast, 2019-2026
10. Middle East & Africa Flow Cytometry Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Flow Cytometry Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Flow Cytometry Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Flow Cytometry Market: Market Share Analysis
11.2. Flow Cytometry Distributors and Customers
11.3. Flow Cytometry Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. DANAHER corporation (Beckman Coulter, Inc.)
11.4.2. Bio-Rad Laboratories Inc.
11.4.3. Luminex Corporation
11.4.4. Sysmex Corporation
11.4.5. Becton
11.4.6. Dickinson and Company